MedTrace Logo

Interoception in Patients With Medically Unexplained Symptoms

NCT05907538 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2023-06-18

No results posted yet for this study

Summary

The goal of this observational study is to learn about interoception in patients with stress related syndromes (overstrain, burnout; SRS) and functional disorder (fibromyalgia/ chronic fatigue syndrome; FD). The main questions it aims to answer are:

* Is there a significant difference in interoception between patients with SRS and healthy controls?
* Is there a significant difference in interoception between patients with FD and healthy controls?
* Is there a significant difference in interoception between patients with SRS and FD?

The participants will perform the respiratory occlusion discrimination task and have to fill out some questionnaires.

Researchers will compare healthy controls to see if there is a significant difference.

Conditions

  • Fibromyalgia
  • Burnout, Psychological

Interventions

OTHER

Interoceptive accuracy measurement

Interoceptive accuracy will be measured using the Respiratory Occlusion Discrimination Task (ROD task; Van Den Houte et al., 2021). The ROD task measures how good subjects are at distinguishing the lengths of short (max 620 milliseconds) inspiratory occlusions (or respiratory interruptions).

OTHER

Interoceptive sensibility measurement

Interoceptive sensibility will be measured using two self-report questionnaires, the The Interoceptive Sensitivity and Attention Questionnaire (ISAQ; Bogaerts et al., 2022) and the the Three-domain Interoceptive Sensations Questionnaire (THISQ; Vlemincx et al., 2021)

OTHER

Interoceptive awareness measurement

Interoceptive awareness will be measures using a visual analogue scale (VAS)

Sponsors & Collaborators

  • TRACE labs Ziekenhuis Oost-Limburg (ZOL)

    collaborator UNKNOWN

  • Hasselt University

    lead OTHER

Principal Investigators

  • Katleen Bogaerts, PhD · Hasselt University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05907538 on ClinicalTrials.gov